Journal Report

Diabetes & metabolism

Download PDF
Journal Information
Journal Title
Diabetes & metabolism
Publisher
ISSN
1262-3636
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Magnetic resonance imaging–defined visceral adiposity beyond body mass index is associated with insulin resistance and early glycemic dysregulation in adults without diabetes
Yuhong Kong, Weiwei Wang, Xuren Sun et al.
2026-11 Vol. 52 Issue 6 Pages 101800
DOI: 10.1016/j.diabet.2026.101800
Interpreting oxygen saturation associations in diabetic neuropathy
Ting Ye
2026-11 Vol. 52 Issue 6 Pages 101798
DOI: 10.1016/j.diabet.2026.101798
Association between diabetes self-management education and glycemic control in patients living with type 2 diabetes in French Guiana: a cross-sectional analysis of the CODIAM cohort study
Gaspard Carbonnier, Yann Lambert, Joseph Fanou et al.
2026-11 Vol. 52 Issue 6 Pages 101795
DOI: 10.1016/j.diabet.2026.101795
Maternal antibody transfer confounds type 1 diabetes screening in infancy: results from the French TRAKR cohort
Sarvenaz Metghalchi, Anna Jones, Elise Bismuth et al.
2026-11 Vol. 52 Issue 6 Pages 101797
DOI: 10.1016/j.diabet.2026.101797
The BCAA paradox: From anabolic nutrients to metabolic signals in insulin resistance
Christophe Magnan, Clara Alcaire, Cedric Moro et al.
2026-11 Vol. 52 Issue 6 Pages 101802
DOI: 10.1016/j.diabet.2026.101802
Cognitive leisure activity and incident dementia among older adults with diabetes: a 5-year prospective cohort study
Yuma Hirano, Takahiro Shimoda, Chika Nakajima et al.
2026-11 Vol. 52 Issue 6 Pages 101805
DOI: 10.1016/j.diabet.2026.101805
Clinical outcomes associated with glucagon-like peptide-1 receptor agonist therapy in patients with peripheral artery disease and diabetes
Haitham Abu Khadija, Mohammad Alnees, Ali Abdullah et al.
2026-11 Vol. 52 Issue 6 Pages 101794
DOI: 10.1016/j.diabet.2026.101794
Beyond glycaemic control: autoimmune polyglandular syndrome type 3 as an emerging distinct entity rather than a mere comorbidity in paediatric type 1 diabetes
Styliani Giza, Vasiliki Rengina Tsinopoulou, Eleni P Kotanidou et al.
2026-11 Vol. 52 Issue 6 Pages 101796
DOI: 10.1016/j.diabet.2026.101796
Efficacy and safety of the dual SGLT1 and SGLT2 inhibitor JP-2266 in Type 2 Diabetes: a randomized, double-blind, placebo-controlled, phase 2 study (Diabetes Metab J, published online July 29, 2026)
Chan Zhang
2026-11 Pages 101804
DOI: 10.1016/j.diabet.2026.101804
Real-world effectiveness of tirzepatide in individuals with obesity: weight response, treatment-related factors and diabetes status
Maria Eugenia Parrotta, Ilaria Milani, Marianna Chinucci et al.
2026-11 Pages 101807
DOI: 10.1016/j.diabet.2026.101807
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 13, 2026 10:03